Cart
sales@molnova.com
Probenecid
CAS No. 57-66-9
Probenecid( NSC 18786 )
Catalog No. M15105 CAS No. 57-66-9
The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1G | 45 | In Stock |
|
Biological Information
-
Product NameProbenecid
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate.
-
DescriptionThe prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 18786
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRPV2
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number57-66-9
-
Formula Weight285.36
-
Molecular FormulaC13H19NO4S
-
Purity>98% (HPLC)
-
SolubilityEthanol: 22 mg/mL (77.09 mM); DMSO: 57 mg/mL (199.74 mM)
-
SMILESCCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
-
Chemical Name4-(dipropylsulfamoyl)benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.McDonough PM, et al. Cell Calcium, 1989, 10(3), 171-180.
molnova catalog
related products
-
SB 452533
SB 452533 is an antagonist of the vanilloid receptor 1(pKb: 7.8).
-
Mogroside V
Mogroside V is a widely used sweetener, has in vitro AMPK activating effect, it also has anti-inflammatory potential in murine macrophages and a murine ear edema model, and has the potential to protect against LPS-induced airway inflammation in a model of ALI.
-
LASSBio-1135
LASSBio-1135 is an orally effective antagonist of TRPV1 and inhibitor of TNF-α production.Oral administration of 100 mol x Kg(-1) LASSBio-1135 markedly reduced thermal hyperalgesia induced by carrageenan.
